ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
R03AK06 | G | Salmeterol (xinafoate) - 50mcg, Fluticasone propionate - 250mcg | 9247 | 78617/1 | FLUDALT DUO | 60 | Capsule, inhalation | Respiratory | Pharmaline S.A.L. | Pharmaline under license from Exeltis Healthcare SL, Spain | Lebanon | 2,265,479 L.L | 23.08 | B | 12/12/20 | 0 |
ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
R03AK06 | B | Salmeterol (xinafoate) - 50mcg/inhalation, Fluticasone propionate - 250mcg/inhalation | 10804 | 129720/1 | SERETIDE DISKUS 250 | 60doses | Inhalation powder | Respiratory | Abela Frères S.A.L. | GlaxoWellcome Production | France | 2,830,132 L.L | 23.08 | B | GlaxoWellcome UK Ltd | UK | 12/12/20 | 0 |